$0.5243
0.1644.83%
Last update: Aug 6, 7:59 PM
$0.5320
0.1746.96%
Ensysce Biosciences Inc
ENSCNASDAQ
PRO
M&A: Cy Biopharma, Inc was acquired by Ensysce Biosciences (ENSC) today
Ensysce Biosciences Earnings & Forecasts
Ensysce Biosciences (ENSC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Ensysce Biosciences Guidance
Recent Earnings Results
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.73 | $-1.26 | $-0.90 | $-1.17 |
| Actual | $-0.52 | $-0.75 | $-1.29 | $-0.79 |
| Surprise | +28.8% | +40.5% | -43.3% | +32.5% |
| Revenue | ||||
| Estimate | $1.9M | $500000 | $1.4M | $923848 |
| Actual | $960999 | $1.9M | $493104 | $1.4M |
| Surprise | -49.4% | +276.4% | -64.8% | +48.4% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q2 '26E | Q3 '26E | Q4 '26E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.50 | $-0.49 | $-0.47 |
| Revenue | |||
| Consensus | $1.9M | $1.9M | — |
